Skip to content

The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.

The Effect of a Home-based Community Pharmacist-led Medication Management Program (HomeCoMe-program) Complementary to an In-hospital Medication Reconciliation Program on Drug-related Problems Post-discharge: A Prospective Cohort Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01897870
Acronym
HomeCoMe
Enrollment
150
Registered
2013-07-12
Start date
2013-11-30
Completion date
2016-02-29
Last updated
2016-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Drug Event, Patient Compliance, Readmission

Keywords

continuity of care, medicines management, home visit, drug-related problems

Brief summary

the purpose of this study is to determine the the effect of a home-based medication management program on drug-related problems post-discharge.

Detailed description

Inaccuracy of medication histories and lack of knowledge on actual medication use results in confusion about medication regimens and medication mismanagement before- during - and after hospital admission. This phenomenon accounts for many readmissions, longer duration of admission and preventable and serious Adverse Drug Events (ADEs) as a result of Drug Related Problems (DRPs). Several studies show that discharge medication reconciliation (MR) and counseling by a pharmacy employee reduces the amount of discrepancies in the discharge prescription lists. Still, no unequivocal effect of MR on the occurrence of DRPs after discharge has been shown. This is due to a shift in underlying potential harmful discrepancies from mainly patient based (unintended nonadherence) to mainly system based (eg dispensing errors) and might be explained by (1) suboptimal transfer of information (2) an overload of information during a stressful situation and (3) difficulty to implement changes in medication at home. Therefore the reduction of DRPs, improvement of patients' medication knowledge and initial adherence can probably most effectively be addressed in a multifaceted integrated transmural intervention. Repetition of important information is the key to success. Moreover, the first weeks following hospital discharge are most crucial in preventing drug-related problems as patients could slip back in old medication schemes, or new problems may arise, such as emerging ADEs due to medication changes made during hospitalization.

Interventions

BEHAVIORALHomeCoMe-program

A home visit by patients own community pharmacist within seven days after hospital discharge. The community pharmacist will perform a semi-structured interview on (1) use of the prescribed medication, (2) ADEs, (3) adherence issues, by (A) assessing patient's needs and concerns around his pharmacotherapy, (B) identifying and solving obstacles for medicines intake, (C) checking on the need for a compliance aid, (D) collecting spare medication and finally (4) knowledge on medication use, when to take which medicine and why, and medication changes made during the hospitalisation.

Sponsors

Zorggroep Almere
CollaboratorOTHER
Flevoziekenhuis
CollaboratorOTHER
H.T. Ensing, PharmD, MSc
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient uses more than three prescribed systemic drugs intended for chronic use at admission and discharge * patient has an expected length of stay of 48 hours or longer

Exclusion criteria

* Patients admitted for scheduled chemotherapy * Patients admitted for radiation therapy * Patients admitted for transplantation * Patients transferred from another hospital * Patients transferred from another non-eligible ward within the same hospital * No informed consent signed * A live expectancy less than 6 months * Inability to be counselled (e.g. cognitive dysfunction, language constraints who cannot be solved with an interpreter) * Discharge to a nursing home (presuming dependence on medication administration) * If patients' community pharmacy is not participating in this study

Design outcomes

Primary

MeasureTime frameDescription
Identifying and solving adverse drug events (ADEs) and other drug-related problems (DRPs) post-dischargewithin 7 days post-dischargeThe total number of assessed and solved ADEs post-discharge will be measured. Assessing and solving ADEs takes place during the pharmacist home visit. Using START-STOPP criteria on patients medication records, ADEs will also be compared between the intervention and usual care group.

Secondary

MeasureTime frameDescription
Improvement of adherence to medication at hospital dischargeup to 6 months after dischargeThe medication possession ratio will be calculated retrospectively from pharmacy dispensing data after 6 months to investigate patient's adherence and compared between the intervention and control group.
Patient assessment of medication knowledge at time of home visitwithin 7 days after dischargeAt time of the home visit patients are asked about their knowledge (e.g. indication, dose regime, etc) regarding the medication they are taking. Knowledge is scored and lack of knowledge is solved by teaching the patient.
Assessment of patient reported health ratingat 14 days after dischargePatient are asked by telephone to report their health on a scale from 1 (worst imaginable health) to 10 (best imaginable health). Number are compared between the intervention and control group.
Patient satisfaction with the pharmacist home visitImmediately after receiving the home visitThe satisfaction survey consists of 13 interview questions, where the subject subjectively scores each question on a four-point scale, developed specifically for this study.
General practitioners satisfaction with the pharmacist home visitImmediately after the home visit is executedThe satisfaction survey consists of 13 interview questions, where the subject subjectively scores each question on a four-point scale, developed specifically for this study.
Types of interventions made at the pharmacist home visitwithin 7 days after dischargeThe types of intervention the pharmacist works on during the 7 day follow-up home visit are assessed.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026